Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Can We Prepare IVF Culture Media Two Days Before Ovum Pick up Without Affecting Embryological Parameters? A Retrospective Case-Matched Study.

Paffoni A, Ballabio E, Cesana S, Ferrari S, Wyssling H, Bianchi MC.

J Reprod Infertil. 2019 Oct-Dec;20(4):209-217.

2.

Rationale for targeting BCL6 in MLL-rearranged acute lymphoblastic leukemia.

Hurtz C, Chan LN, Geng H, Ballabio E, Xiao G, Deb G, Khoury H, Chen CW, Armstrong SA, Chen J, Ernst P, Melnick A, Milne T, Müschen M.

Genes Dev. 2019 Sep 1;33(17-18):1265-1279. doi: 10.1101/gad.327593.119. Epub 2019 Aug 8.

PMID:
31395741
3.

The basic helix-loop-helix transcription factor SHARP1 is an oncogenic driver in MLL-AF6 acute myelogenous leukemia.

Numata A, Kwok HS, Kawasaki A, Li J, Zhou QL, Kerry J, Benoukraf T, Bararia D, Li F, Ballabio E, Tapia M, Deshpande AJ, Welner RS, Delwel R, Yang H, Milne TA, Taneja R, Tenen DG.

Nat Commun. 2018 Apr 24;9(1):1622. doi: 10.1038/s41467-018-03854-0.

4.

MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia.

Kerry J, Godfrey L, Repapi E, Tapia M, Blackledge NP, Ma H, Ballabio E, O'Byrne S, Ponthan F, Heidenreich O, Roy A, Roberts I, Konopleva M, Klose RJ, Geng H, Milne TA.

Cell Rep. 2017 Jan 10;18(2):482-495. doi: 10.1016/j.celrep.2016.12.054.

5.

MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation.

Godfrey L, Kerry J, Thorne R, Repapi E, Davies JO, Tapia M, Ballabio E, Hughes JR, Geng H, Konopleva M, Milne TA.

Exp Hematol. 2017 Mar;47:64-75. doi: 10.1016/j.exphem.2016.11.003. Epub 2016 Nov 14.

6.

MLL-Rearranged Acute Lymphoblastic Leukemias Activate BCL-2 through H3K79 Methylation and Are Sensitive to the BCL-2-Specific Antagonist ABT-199.

Benito JM, Godfrey L, Kojima K, Hogdal L, Wunderlich M, Geng H, Marzo I, Harutyunyan KG, Golfman L, North P, Kerry J, Ballabio E, Chonghaile TN, Gonzalo O, Qiu Y, Jeremias I, Debose L, O'Brien E, Ma H, Zhou P, Jacamo R, Park E, Coombes KR, Zhang N, Thomas DA, O'Brien S, Kantarjian HM, Leverson JD, Kornblau SM, Andreeff M, Müschen M, Zweidler-McKay PA, Mulloy JC, Letai A, Milne TA, Konopleva M.

Cell Rep. 2015 Dec 29;13(12):2715-27. doi: 10.1016/j.celrep.2015.12.003. Epub 2015 Dec 17.

7.

Self-enforcing feedback activation between BCL6 and pre-B cell receptor signaling defines a distinct subtype of acute lymphoblastic leukemia.

Geng H, Hurtz C, Lenz KB, Chen Z, Baumjohann D, Thompson S, Goloviznina NA, Chen WY, Huan J, LaTocha D, Ballabio E, Xiao G, Lee JW, Deucher A, Qi Z, Park E, Huang C, Nahar R, Kweon SM, Shojaee S, Chan LN, Yu J, Kornblau SM, Bijl JJ, Ye BH, Ansel KM, Paietta E, Melnick A, Hunger SP, Kurre P, Tyner JW, Loh ML, Roeder RG, Druker BJ, Burger JA, Milne TA, Chang BH, Müschen M.

Cancer Cell. 2015 Mar 9;27(3):409-25. doi: 10.1016/j.ccell.2015.02.003.

8.

Epigenetic control of gene expression in leukemogenesis: Cooperation between wild type MLL and MLL fusion proteins.

Ballabio E, Milne TA.

Mol Cell Oncol. 2014 Oct 29;1(2):e955330. doi: 10.1080/23723548.2014.955330. eCollection 2014 Apr-Jun. Review.

9.

Considerations on a mutation in the NOTCH3 gene sparing a cysteine residue: a rare polymorphism rather than a CADASIL variant.

Bersano A, Ranieri M, Ciammola A, Cinnante C, Lanfranconi S, Dotti MT, Candelise L, Baschirotto C, Ghione I, Ballabio E, Bresolin N, Bassi MT.

Funct Neurol. 2012 Oct-Dec;27(4):247-52.

10.

RUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction.

Wilkinson AC, Ballabio E, Geng H, North P, Tapia M, Kerry J, Biswas D, Roeder RG, Allis CD, Melnick A, de Bruijn MF, Milne TA.

Cell Rep. 2013 Jan 31;3(1):116-27. doi: 10.1016/j.celrep.2012.12.016. Epub 2013 Jan 24.

11.

Bortezomib action in multiple myeloma: microRNA-mediated synergy (and miR-27a/CDK5 driven sensitivity)?

Ballabio E, Armesto M, Breeze CE, Manterola L, Arestin M, Tramonti D, Hatton CS, Lawrie CH.

Blood Cancer J. 2012 Aug 24;2:e83. doi: 10.1038/bcj.2012.31. No abstract available.

12.

Primary cutaneous anaplastic large cell lymphoma shows a distinct miRNA expression profile and reveals differences from tumor-stage mycosis fungoides.

Benner MF, Ballabio E, van Kester MS, Saunders NJ, Vermeer MH, Willemze R, Lawrie CH, Tensen CP.

Exp Dermatol. 2012 Aug;21(8):632-4. doi: 10.1111/j.1600-0625.2012.01548.x.

PMID:
22776000
13.

Inter- and intra-observational variability in immunohistochemistry: a multicentre analysis of diffuse large B-cell lymphoma staining.

Lawrie CH, Ballabio E, Soilleux E, Sington J, Hatton CS, Dirnhofer S, Tzankov A.

Histopathology. 2012 Jul;61(1):18-25. doi: 10.1111/j.1365-2559.2012.04179.x. Epub 2012 Feb 28.

PMID:
22372580
14.

Molecular and Epigenetic Mechanisms of MLL in Human Leukemogenesis.

Ballabio E, Milne TA.

Cancers (Basel). 2012 Sep 10;4(3):904-44. doi: 10.3390/cancers4030904.

15.

Superficial siderosis due to dural defect with thoracic spinal cord herniation.

Boncoraglio GB, Ballabio E, Erbetta A, Prada F, Savoiardo M, Parati EA.

J Neurol Sci. 2012 Jan 15;312(1-2):170-2. doi: 10.1016/j.jns.2011.07.034. Epub 2011 Aug 24.

PMID:
21868040
16.

Genomic imbalances are confined to non-proliferating cells in paediatric patients with acute myeloid leukaemia and a normal or incomplete karyotype.

Ballabio E, Regan R, Garimberti E, Harbott J, Bradtke J, Teigler-Schlegel A, Biondi A, Cazzaniga G, Giudici G, Wainscoat JS, Boultwood J, Bridger JM, Knight SJ, Tosi S.

PLoS One. 2011;6(6):e20607. doi: 10.1371/journal.pone.0020607. Epub 2011 Jun 9.

17.

MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival.

Chi J, Ballabio E, Chen XH, Kušec R, Taylor S, Hay D, Tramonti D, Saunders NJ, Littlewood T, Pezzella F, Boultwood J, Wainscoat JS, Hatton CS, Lawrie CH.

Biol Direct. 2011 May 18;6:23. doi: 10.1186/1745-6150-6-23.

18.

miRNA expression profiling of mycosis fungoides.

van Kester MS, Ballabio E, Benner MF, Chen XH, Saunders NJ, van der Fits L, van Doorn R, Vermeer MH, Willemze R, Tensen CP, Lawrie CH.

Mol Oncol. 2011 Jun;5(3):273-80. doi: 10.1016/j.molonc.2011.02.003. Epub 2011 Feb 24.

19.

The Causative Classification of Stroke system: an international reliability and optimization study.

Arsava EM, Ballabio E, Benner T, Cole JW, Delgado-Martinez MP, Dichgans M, Fazekas F, Furie KL, Illoh K, Jood K, Kittner S, Lindgren AG, Majersik JJ, Macleod MJ, Meurer WJ, Montaner J, Olugbodi AA, Pasdar A, Redfors P, Schmidt R, Sharma P, Singhal AB, Sorensen AG, Sudlow C, Thijs V, Worrall BB, Rosand J, Ay H; International Stroke Genetics Consortium.

Neurology. 2010 Oct 5;75(14):1277-84. doi: 10.1212/WNL.0b013e3181f612ce. Erratum in: Neurology. 2011 Jan 11;76(2):202.

20.

Comparison of Choi and Hans' algorithms by immunohistochemistry and quantitative reverse transcriptase-PCR - letter.

Ballabio E, Chi J, Roncador G, Banham AH, Hatton CS, Lawrie CH.

Clin Cancer Res. 2010 Jul 15;16(14):3805-6. doi: 10.1158/1078-0432.CCR-09-3216. Epub 2010 Jul 13. No abstract available.

21.

Stenting for the treatment of high-grade intracranial stenoses.

Lanfranconi S, Bersano A, Branca V, Ballabio E, Isalberti M, Papa R, Candelise L.

J Neurol. 2010 Nov;257(11):1899-908. doi: 10.1007/s00415-010-5633-1. Epub 2010 Jul 4.

PMID:
20602237
22.

MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential.

Ballabio E, Mitchell T, van Kester MS, Taylor S, Dunlop HM, Chi J, Tosi I, Vermeer MH, Tramonti D, Saunders NJ, Boultwood J, Wainscoat JS, Pezzella F, Whittaker SJ, Tensen CP, Hatton CS, Lawrie CH.

Blood. 2010 Aug 19;116(7):1105-13. doi: 10.1182/blood-2009-12-256719. Epub 2010 May 6.

23.

A cortically blind patient with preserved visual imagery.

Zago S, Corti S, Bersano A, Baron P, Conti G, Ballabio E, Lanfranconi S, Cinnante C, Costa A, Cappellari A, Bresolin N.

Cogn Behav Neurol. 2010 Mar;23(1):44-8. doi: 10.1097/WNN.0b013e3181bf2e6e.

PMID:
20299863
24.

The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation.

Marafioti T, Paterson JC, Ballabio E, Chott A, Natkunam Y, Rodriguez-Justo M, Plonquet A, Rodriguez-Pinilla SM, Klapper W, Hansmann ML, Pileri SA, Isaacson PG, Stein H, Piris MA, Mason DY, Gaulard P.

Haematologica. 2010 Mar;95(3):432-9. doi: 10.3324/haematol.2009.010991.

25.

Intra-arterial or intravenous thrombolysis for acute ischemic stroke? The SYNTHESIS pilot trial.

Ciccone A, Valvassori L, Ponzio M, Ballabio E, Gasparotti R, Sessa M, Scomazzoni F, Tiraboschi P, Sterzi R; SYNTHESIS Investigators.

J Neurointerv Surg. 2010 Mar;2(1):74-9. doi: 10.1136/jnis.2009.001388. Epub 2009 Oct 30.

PMID:
21990564
26.

MicroRNA expression in chronic lymphocytic leukaemia.

Lawrie CH, Ballabio E, Dyar OJ, Jones M, Ventura R, Chi J, Tramonti D, Gooding S, Boultwood J, Wainscoat JS, Hatton CS, Schuh A.

Br J Haematol. 2009 Nov;147(3):398-402. doi: 10.1111/j.1365-2141.2009.07857.x. Epub 2009 Aug 13. No abstract available.

PMID:
19681887
27.

Clinical studies in stem cells transplantation for stroke: a review.

Bersano A, Ballabio E, Lanfranconi S, Boncoraglio GB, Corti S, Locatelli F, Baron P, Bresolin N, Parati E, Candelise L.

Curr Vasc Pharmacol. 2010 Jan;8(1):29-34. Review.

28.

Transthyretin Asn90 variant: amyloidogenic or non-amyloidogenic role.

Bersano A, Del Bo R, Ballabio E, Cinnante C, Lanfranconi S, Comi GP, Baron P, Bresolin N, Candelise L.

J Neurol Sci. 2009 Sep 15;284(1-2):113-5. doi: 10.1016/j.jns.2009.04.015. Epub 2009 May 9.

PMID:
19428025
29.

Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma.

Lawrie CH, Chi J, Taylor S, Tramonti D, Ballabio E, Palazzo S, Saunders NJ, Pezzella F, Boultwood J, Wainscoat JS, Hatton CS.

J Cell Mol Med. 2009 Jul;13(7):1248-60. doi: 10.1111/j.1582-4934.2008.00628.x. Epub 2008 Dec 24.

30.

Aberrant expression of microRNA biosynthetic pathway components is a common feature of haematological malignancy.

Lawrie CH, Cooper CD, Ballabio E, Chi J, Tramonti D, Hatton CS.

Br J Haematol. 2009 May;145(4):545-8. doi: 10.1111/j.1365-2141.2009.07642.x. Epub 2008 Mar 2. No abstract available.

PMID:
19298586
31.

Ectopic expression of the HLXB9 gene is associated with an altered nuclear position in t(7;12) leukaemias.

Ballabio E, Cantarella CD, Federico C, Di Mare P, Hall G, Harbott J, Hughes J, Saccone S, Tosi S.

Leukemia. 2009 Jun;23(6):1179-82. doi: 10.1038/leu.2009.15. Epub 2009 Feb 12. No abstract available.

PMID:
19212340
32.

Safety of carotid stenting for stroke prevention: need of an independent outcome assessor.

Lanfranconi S, Bersano A, D'Adda E, Ballabio E, Gattinoni M, Cinnante C, Nuzzi P, Isalberti M, Branca V, Candelise L.

Neurol Sci. 2009 Apr;30(2):93-7. doi: 10.1007/s10072-009-0012-3. Epub 2009 Feb 3.

PMID:
19189045
33.

Stem cell therapy in stroke.

Locatelli F, Bersano A, Ballabio E, Lanfranconi S, Papadimitriou D, Strazzer S, Bresolin N, Comi GP, Corti S.

Cell Mol Life Sci. 2009 Mar;66(5):757-72. doi: 10.1007/s00018-008-8346-1. Review.

PMID:
18989624
34.

Statins and stroke.

Bersano A, Ballabio E, Lanfranconi S, Mazzucco S, Candelise L, Monaco S.

Curr Med Chem. 2008;15(23):2380-92. Review.

PMID:
18855667
35.

Recovery after L-DOPA treatment in peginterferon and ribavirin induced parkinsonism.

Bersano A, Aghemo A, Rumi MG, Ballabio E, Candelise L, Colombo M.

Eur J Intern Med. 2008 Jul;19(5):370-1. doi: 10.1016/j.ejim.2007.10.003. Epub 2007 Nov 28.

PMID:
18549943
36.

Labeling of multiple cell markers and mRNA using automated apparatus.

Paterson JC, Ballabio E, Mattsson G, Turner SH, Mason DY, Marafioti T.

Appl Immunohistochem Mol Morphol. 2008 Jul;16(4):371-81. doi: 10.1097/PAI.0b013e318164fc63.

PMID:
18528279
37.

Genetic polymorphisms for the study of multifactorial stroke.

Bersano A, Ballabio E, Bresolin N, Candelise L.

Hum Mutat. 2008 Jun;29(6):776-95. doi: 10.1002/humu.20666. Review.

PMID:
18421701
38.

Novel markers of normal and neoplastic human plasmacytoid dendritic cells.

Marafioti T, Paterson JC, Ballabio E, Reichard KK, Tedoldi S, Hollowood K, Dictor M, Hansmann ML, Pileri SA, Dyer MJ, Sozzani S, Dikic I, Shaw AS, Petrella T, Stein H, Isaacson PG, Facchetti F, Mason DY.

Blood. 2008 Apr 1;111(7):3778-92. doi: 10.1182/blood-2007-10-117531. Epub 2008 Jan 24.

PMID:
18218851
39.

Inclusion body myopathy and frontotemporal dementia caused by a novel VCP mutation.

Bersano A, Del Bo R, Lamperti C, Ghezzi S, Fagiolari G, Fortunato F, Ballabio E, Moggio M, Candelise L, Galimberti D, Virgilio R, Lanfranconi S, Torrente Y, Carpo M, Bresolin N, Comi GP, Corti S.

Neurobiol Aging. 2009 May;30(5):752-8. Epub 2007 Sep 24.

PMID:
17889967
40.

Amino acid changes in the amino terminus of the Na,K-adenosine triphosphatase alpha-2 subunit associated to familial and sporadic hemiplegic migraine.

Tonelli A, Gallanti A, Bersano A, Cardin V, Ballabio E, Airoldi G, Redaelli F, Candelise L, Bresolin N, Bassi MT.

Clin Genet. 2007 Dec;72(6):517-23. Epub 2007 Sep 18.

PMID:
17877748
41.

Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma.

Roncador G, García Verdes-Montenegro JF, Tedoldi S, Paterson JC, Klapper W, Ballabio E, Maestre L, Pileri S, Hansmann ML, Piris MA, Mason DY, Marafioti T.

Haematologica. 2007 Aug;92(8):1059-66. Epub 2007 Jul 20.

42.

Monogenic vessel diseases related to ischemic stroke: a clinical approach.

Ballabio E, Bersano A, Bresolin N, Candelise L.

J Cereb Blood Flow Metab. 2007 Oct;27(10):1649-62. Epub 2007 Jun 20. Review.

43.

Debunking 7 myths that hamper the realization of randomized controlled trials on intra-arterial thrombolysis for acute ischemic stroke.

Ciccone A, Valvassori L, Gasparotti R, Scomazzoni F, Ballabio E, Sterzi R.

Stroke. 2007 Jul;38(7):2191-5. Epub 2007 May 31.

PMID:
17540973
44.
45.
46.

The dual role of endothelial differentiation-related factor-1 in the cytosol and nucleus: modulation by protein kinase A.

Ballabio E, Mariotti M, De Benedictis L, Maier JA.

Cell Mol Life Sci. 2004 May;61(9):1069-74.

PMID:
15112053
47.

Endothelial stress by gravitational unloading: effects on cell growth and cytoskeletal organization.

Carlsson SI, Bertilaccio MT, Ballabio E, Maier JA.

Biochim Biophys Acta. 2003 Oct 21;1642(3):173-9.

48.

Promoter analysis of TFPT (FB1), a molecular partner of TCF3 (E2A) in childhood acute lymphoblastic leukemia.

Brambillasca F, Mosna G, Ballabio E, Biondi A, Boulukos KE, Privitera E.

Biochem Biophys Res Commun. 2001 Nov 16;288(5):1250-7.

PMID:
11700047
49.

Warfarin enantiomers, anticoagulation, and experimental tumour metastasis.

Poggi A, Mussoni L, Kornblihtt L, Ballabio E, de Gaetano G, Donati MB.

Lancet. 1978 Jan 21;1(8056):163-4. No abstract available.

PMID:
87609

Supplemental Content

Loading ...
Support Center